Glyco-binding domain chimeric antigen receptors as a new option for cancer immunotherapy
Klinische Pädiatrie · 01.05.2024 · 236 (03) · 204-205
DOI: 10.1055/s-0044-1786574 ↗Kurz gefasst
Fachartikel in der Zeitschrift Klinische Pädiatrie, erschienen am 01.05.2024. Verfasst von A K Franke und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Glyco-binding domain chimeric antigen receptors as a new option for cancer immunotherapy
Zitieren
APA
Franke, A. K., Prasse, N., Almohamady, J., Wessolowski, C., Müller, I., & Cornils, K. (2024). Glyco-binding domain chimeric antigen receptors as a new option for cancer immunotherapy. Klinische Pädiatrie, 236(03), 204-205. https://doi.org/10.1055/s-0044-1786574
Vancouver
Franke AK, Prasse N, Almohamady J, Wessolowski C, Müller I, Cornils K. Glyco-binding domain chimeric antigen receptors as a new option for cancer immunotherapy. Klinische Pädiatrie. 2024;236(03):204-205. doi:10.1055/s-0044-1786574
BibTeX
@article{Franke2024,
author = {Franke, A K and Prasse, N and Almohamady, J and Wessolowski, C and Müller, I and Cornils, K},
title = {Glyco-binding domain chimeric antigen receptors as a new option for cancer immunotherapy},
journal = {Klinische Pädiatrie},
year = {2024},
volume = {236},
number = {03},
pages = {204--205},
doi = {10.1055/s-0044-1786574}
}
EUVIMED